A Comprehensive Approach to the Safe Management of Extended-Release/Long-Acting Opioids
A CME/CE-certified Symposium in conjunction with the PAINWeek 2016 Annual Meeting



Registration Statement


By clicking the Registration Button below you are agreeing that you have read and understood the CME Statements below.


Registration

  VenueCityStateDate
View Agenda  The Cosmopolitan
Room Name: Gracia 3, Level 3
Las VegasNV Tuesday
Sep 6, 2016 1:40 PM


Presentation Slides:

Download (PDF) Click here to view the presentation slides from this symposium.

Click here to view the presentation slides from this symposium. (Coming Soon)

Program Description:

Pain is a significant public health problem, affecting more than 100 million adults in the US and causing significant reductions in patients’ quality of life. The use of narcotic medications for pain management has increased dramatically in the US over the past two decades. However, pain patients are often undertreated due to a variety of physician- and patient-related concerns and barriers.

In addition, despite the pain-relieving properties of opioid medications, the potential for abuse remains a concern. In response to this apprehension about opioid misuse, overdose, abuse, and addiction, the Food and Drug Administration (FDA) developed the Risk Evaluation and Mitigation Strategy (REMS) to ensure that the benefits outweigh the risks for long-acting and extended-release opioid analgesics.

This activity, A Comprehensive Approach to the Safe Management of Extended-Release/Long-Acting Opioids, incorporates the REMS blueprint into education that is designed to induce changes in knowledge, competence, and performance that will translate into improved quality of patient care and reduced pain for patients.

Agenda:

  1. Welcome and Introduction
  2. Pain: A Public Health Issue
  3. Recognizing the Barriers in Effective Pain Management
  4. REMS: Extended Release Opioids and Abuse Deterrent Formulations: What Prescribers Need to Know
  5. Improving the Management of Pain Through Patient Engagement
  6. Q&A session and Concluding Remarks

Target Audience:

This education is intended for primary care providers and other clinicians involved in pain management, and is designed to help them recognize and balance optimal pain reduction to improve function and productivity with minimization of adverse events (e.g. abuse, addiction, and risk of workplace accidents). Additional challenges to optimal pain management include keeping up to date with the increasing volume of information on pain management, implementing changes recommended by evolving guidelines, and recognizing changes to practice needed to combat the growing rate of opioid abuse.

Educational Objectives:

At the conclusion of this activity, participants should be able to demonstrate the ability to:

  • Describe how to counsel patients and caregivers on safe use of ER/LA opioid analgesics, including proper storage and disposal
  • Review how to safely initiate therapy, modify dose, and discontinue use
  • Explain general and product-specific drug information
  • Identify patients who are candidates for treatment with ER/LA opioid analgesics
  • Describe how to minimize risks of opioid abuse, addiction, diversion while managing patients who are receiving ongoing therapy

Program Faculty

Jeffrey Gudin, MD
Director, Pain and Palliative Care
Englewood Hospital and Medical Center
Clinical Instructor, Anesthesiology
Icahn School of Medicine at Mount Sinai
Englewood, NJ

Bill McCarberg, MD
Adjunct Assistant Clinical Professor
University of California San Diego
Neighborhood Healthcare
San Diego, CA

Steering Committee

Jeffrey Gudin, MD
Director, Pain and Palliative Care
Englewood Hospital and Medical Center
Clinical Instructor, Anesthesiology
Icahn School of Medicine at Mount Sinai
Englewood, NJ

Steven D. Passik, PhD
Pain Psychologist
San Diego, CA

Lynn Webster, MD
Vice President of Scientific Affairs
PRA Health Sciences
Salt Lake City, UT

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Rockpointe Corporation. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 3.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's COA.

This educational activity for 3.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

Global Education Group designates this continuing education activity for 3.0 contact hours (0.3 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-16-105-L01-P).

This is a knowledge based activity.

Nurse Practitioner Continuing Education


Global Education Group is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 110121. This program has been approved for 3.0 contact hours of continuing education (which includes 0.5 hours of pharmacology).

Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 3.0 hours of Category 1 credit for completing this program.

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com.

Instructions for Obtaining Credit

To receive credit learners must complete pre-test, post-test, and evaluation.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosure Information

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Disclosure of Unlabeled Use

This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Rockpointe Corporation do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Special Services

Event staff will be glad to assist you with any special needs. Please email specialservices@rockpointe-pcme.com at least 5 days prior to the program.

This course is not intended to advocate for the use of Extended-Release/Long-Acting (ER/LA) Opioids, but to ensure the proper education about safe prescribing practices should a medical provider determine that ER/LA Opioids are the best course of treatment.

PROVIDED By

Jointly provided by Global Education Group and Rockpointe


      

SUPPORTED BY

This educational activity is supported by an independent educational grant from the ER/LS Opioid Analgesic REMS Program Companies.

Please see:http://ce.er-la-opioidrems.com/IwgCEUI/rems/pdf/List_of_RPC_Companies.pdf for a listing of the member companies. This activity is intended to be fully compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the US Food & Drug Administration.

This program was planned in accordance with AANP CE Standards and Policies and the AANP Commercial Support Standard.



Registration

  VenueCityStateDate
View Agenda  The Cosmopolitan
Room Name: Gracia 3, Level 3
Las VegasNV Tuesday
Sep 6, 2016 1:40 PM